|
|
||||||||
1 From the Department of Life Science, Aichi University of Education; and the 2 Department of Ophthalmology, 3 Division of Pathobiology, and 4 Division of Pathology, Juntendo University, School of Medicine, Tokyo, Japan.
PURPOSE. Macular corneal dystrophy (MCD) is an autosomal recessive inherited disorder that is accompanied by corneal opacity. Explants from MCD-affected corneas have been reported to synthesize low-sulfated KS, suggesting that sulfate groups attached to KS may play critical roles in maintaining corneal transparency. To clear the biosynthetic defect in the MCD cornea, sulfotransferase activities were determined that are presumably involved in the biosynthesis of KS: galactose-6-sulfotransferase (Gal6ST) activity and N-acetylglucosamine 6-O-sulfotransferase (GlcNAc6ST) activity.
METHODS. Gal6ST and GlcNAc6ST activities, which were contained in the corneal extracts from corneas affected by MCD and keratoconus and from normal control corneas, were determined by measuring the transfer of 35SO4 from [35S]3'-phosphoadenosine 5'-phosphosulfate into the Gal residue of partially desulfated KS and the nonreducing terminal GlcNAc residue of GlcNAcß1-3Galß1-4GlcNAc (oligo A), respectively.
RESULTS. The level of Gal6ST activity in corneal extracts from eyes with MCD, which was measured by using partially desulfated KS as an acceptor, was nearly equal to that in eyes with keratoconus and normal control eyes. In contrast, GlcNAc6ST activity in the extracts from MCD-affected corneas, which was measured by using oligo A as an acceptor, was much lower than in those in corneas with keratoconus and in normal control corneas.
CONCLUSIONS. The decrease in GlcNAc6ST activity in the cornea with MCD may result in the occurrence of low- or nonsulfated KS and thereby cause corneal opacity.
This article has been cited by other articles:
![]() |
H. Xu, H. Kurihara, T. Ito, H. Kikuchi, K. Yoshida, H. Yamanokuchi, and A. Asari The Keratan Sulfate Disaccharide Gal(6S03) {beta}1,4-GlcNAc(6S03) Modulates Interleukin 12 Production by Macrophages in Murine Thy-1 Type Autoimmune Disease J. Biol. Chem., May 27, 2005; 280(21): 20879 - 20886. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Warren, A. J. Aldave, M. Srinivasan, E. J. Thonar, A. B. Kumar, V. Cevallos, J. P. Whitcher, and T. P. Margolis Novel Mutations in the CHST6 Gene Associated With Macular Corneal Dystrophy in Southern India Arch Ophthalmol, November 1, 2003; 121(11): 1608 - 1612. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Iida-Hasegawa, A. Furuhata, H. Hayatsu, A. Murakami, K. Fujiki, K. Nakayasu, and A. Kanai Mutations in the CHST6 Gene in Patients with Macular Corneal Dystrophy: Immunohistochemical Evidence of Heterogeneity Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3272 - 3277. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. Ha, H. M. Chau, L. X. Cung, T. K. Thanh, K. Fujiki, A. Murakami, Y. Hiratsuka, and A. Kanai Mutation Analysis of the Carbohydrate Sulfotransferase Gene in Vietnamese with Macular Corneal Dystrophy Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3310 - 3316. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Niel, P. Ellies, P. Dighiero, J. Soria, C. Sabbagh, C. San, G. Renard, M. Delpech, and S. Valleix Truncating Mutations in the Carbohydrate Sulfotransferase 6 Gene (CHST6) Result in Macular Corneal Dystrophy Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 2949 - 2953. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Lee, A. Bistrup, A. Van Zante, and S. D. Rosen Activities and expression pattern of the carbohydrate sulfotransferase GlcNAc6ST-3 (I-GlcNAc6ST): functional implications Glycobiology, April 1, 2003; 13(4): 245 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. El-Ashry, M. M. A. El-Aziz, S. Wilkins, M. E. Cheetham, S. E. Wilkie, A. J. Hardcastle, S. Halford, A. Y. Bayoumi, L. A. Ficker, S. Tuft, et al. Identification of Novel Mutations in the Carbohydrate Sulfotransferase Gene (CHST6) Causing Macular Corneal Dystrophy Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 377 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Plaas, L. A. West, E. J. A. Thonar, Z. A. Karcioglu, C. J. Smith, G. K. Klintworth, and V. C. Hascall Altered Fine Structures of Corneal and Skeletal Keratan Sulfate and Chondroitin/Dermatan Sulfate in Macular Corneal Dystrophy J. Biol. Chem., October 19, 2001; 276(43): 39788 - 39796. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Quantock, K. M. Meek, and S. Chakravarti An X-ray Diffraction Investigation of Corneal Structure in Lumican-Deficient Mice Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1750 - 1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Akama, J. Nakayama, K. Nishida, N. Hiraoka, M. Suzuki, J. McAuliffe, O. Hindsgaul, M. Fukuda, and M. N. Fukuda Human Corneal GlcNAc 6-O-Sulfotransferase and Mouse Intestinal GlcNAc 6-O-Sulfotransferase Both Produce Keratan Sulfate J. Biol. Chem., May 4, 2001; 276(19): 16271 - 16278. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |